| Financial Year |
March 31 2023 |
| Monetary Funds |
432,700,348.67 |
| Held-for-trading Financial Assets |
223,888,004.21 |
| Notes Receivable |
9,865,911.83 |
| Accounts Receivable |
310,925,641.78 |
| Advances to Suppliers |
2,299,233.93 |
| Other Receivables |
5,073,684.21 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
92,441,926.47 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
6,704,825.83 |
| Total Current Assets |
1,086,679,696.54 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
201,918,286.48 |
| Under-construction Projects |
83,122,237.50 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
34,650,964.21 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,422,809.66 |
| Deferred Income Tax Assets |
6,551,304.95 |
| Other Non-Current Assets |
5,864,987.57 |
| Sub-Total of Non-Current Assets |
339,254,984.14 |
| Total Assets |
1,425,934,680.68 |
| Short-Term Loans |
166,500,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
9,669,592.35 |
| Accounts Payable |
173,249,603.30 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
5,777,079.13 |
| Taxes Payable |
2,669,653.06 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
26,916,578.42 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,634,408.49 |
| Other Current Liabilities |
83,949.84 |
| Sub-Total of Current Liabilities |
387,146,632.59 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
15,771,438.08 |
| Total Liabilities |
402,918,070.67 |
| Paid-In Capital(Or Share Stock) |
73,099,561.00 |
| Capital Surplus |
629,936,069.86 |
| Surplus Reserve |
15,877,066.15 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
303,838,510.40 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,023,016,610.01 |
| Owner's Equity（Stockholder's Equity） |
1,023,016,610.01 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,425,934,680.68 |
